Point-of-care diagnostics and resistance phenotyping to combat ash dieback

Abstract

Non-destructive tree phenotyping for resistance screening and early, presymptomatic disease detection figures prominently among the most important practical limitations inherent in forest health management. The need for point-of-care tools is particularly acute for managing diseases caused by non-native pathogens, often resulting in difficult-to-control biological invasions. One such case is represented by ash dieback in Europe, caused by Hymenoscyphus fraxineus, which has led Sweden to red-list its main host, European ash ( Fraxinus excelsior ). We evaluated the use of near-infrared (NIR) spectroscopy and machine learning for detection of presymptomatic infections by H. fraxineus and identification of disease-resistance European ash accessions. Here, we show that presymptomatic infected trees can be distinguished from pathogen-free trees with a testing error rate of 0.161 in a controlled inoculation experiment. We also show that the same approach can be used to identify disease-resistant European ash accessions based on data from two independent, multiyear clonal trials, with a testing error rate of 0.155. These results confirm that NIR spectroscopy combined with machine learning is sensitive enough for early disease detection and resistance screening in this system. This is consistent with prior findings in other tree pathosystems and suggests that this approach could be developed into an operational tool to facilitate the management of biological invasions of forest environments by non-native pathogens, including habitat restoration with resistant germplasm.

Plant phenotyping relevance

NIR分光と機械学習を用いて、感染樹の病徴状態と病害抵抗性を非破壊・早期推定する方法を評価しており、植物フェノタイピング手法の開発・検証が中心である。

Code and data availability

The paper's NIR spectral/phenotype datasets (presymptomatic infection detection and resistance phenotyping of European ash) are deposited publicly on Dryad under DOI 10.5061/dryad.s1rn8pkkn, per the data availability statement. No author analysis code repository is stated; cited R packages (caret, FDA, R) are generic,非